about
Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic DiseasesEpidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.Physicians report barriers to deliver best practice care for asplenic patients: a cross-sectional surveySubtotal splenectomy for splenomegaly in cirrhotic patientsFunctional hyposplenism.Antibody response to Haemophilus influenzae type-b conjugate vaccine in children and young adults with congenital asplenia or after undergoing splenectomyRecommended vaccinations for asplenic and hyposplenic adult patientsAssessment of splenic function.Conjugate and 23-valent pneumococcal polysaccharide booster vaccination in asplenic patients with thalassemia major: A randomized clinical trial study.Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes.Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count.Bovine Serum Albumin-Glutaraldehyde Sealed Fish-Mouth Closure of the Pancreatic Remnant during Distal Pancreatectomy.Brucellosis-induced autoimmune hemolytic anemia treated with rituximab.Need for a national database for splenic trauma?Sporadic isolated congenital asplenia with fulminant pneumococcal meningitis: a case report and updated literature review.A multicenter survey on distal pancreatectomy in Italy: results of minimally invasive technique and variability of perioperative pathways.Mesenteric lymph nodes are not required for an intestinal immunoglobulin A response to oral cholera toxin
P2860
Q26778773-171A5254-1359-4AC9-B989-02DB03065963Q30431534-C00B97DD-EB54-4042-B135-48C0F70EA202Q33851641-522C11E9-4514-4051-893B-8DD9E23CA58FQ34121460-DC67E1B6-6954-4E8D-8BB5-943B31DEF8A0Q34433706-7AF928D2-28C2-4BC5-9752-89BB6C3C302FQ35871915-567CAE7B-FA1E-4DB3-9EA7-46B75CA8175AQ37669423-028D3B66-7A72-4148-B14A-EDA97636BCA8Q37790319-2BEF28B1-0532-4755-B0E7-D06E6BCF4737Q40213372-945645FF-85A2-4112-A411-DD6838EFC04DQ41706209-5A1800C2-241B-44E2-A689-AB4F2CEC277FQ42259145-7215BAEE-3BA1-4577-8B56-F823471B5A31Q42325865-CE5A2ACA-30EC-4131-B55A-20E5002BD9C0Q42914762-E7AA9686-887F-4F1D-903D-A352CD4A35FDQ43068600-9E7401C8-EDC6-4A9C-86B9-A65B4193C81DQ47161699-A6E38A21-0DC8-490F-B982-139F52B559F8Q51007080-F155F8B9-B3D4-48B9-87D4-39259A5A10D8Q57126727-90C7260A-45D2-4FCB-92B8-19A70BD80611
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vaccination of asplenic or hyposplenic adults.
@en
Vaccination of asplenic or hyposplenic adults.
@nl
type
label
Vaccination of asplenic or hyposplenic adults.
@en
Vaccination of asplenic or hyposplenic adults.
@nl
prefLabel
Vaccination of asplenic or hyposplenic adults.
@en
Vaccination of asplenic or hyposplenic adults.
@nl
P2093
P356
P1476
Vaccination of asplenic or hyposplenic adults
@en
P2093
E G Mourtzoukou
M E Falagas
P304
P356
10.1002/BJS.6106
P407
P50
P577
2008-03-01T00:00:00Z